CALLOS ANDREW (Chief Commercial Officer) sold 14.6% of their position (10K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $702.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/31/2026ACC: 0001061983-26-000090
Officer· Chief Commercial Officer
Since Mar 2021
-10K
Net shares
Net seller
$702.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$23.26
Trade value
$232.60K
% of position
17.1%
8/31/2026
58.55K→68.56K
Common Stock
Direct
Shares
−10K
Price / share
$70.24
Trade value
$702.40K
% of position
14.6%
8/31/2026
68.56K→58.55K
Total
Net shares
+0.00
Net value
-$469.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2026 | M · Option Exercise | +10K | $23.26 | $232.60K | 17.1% | 58.55K | 68.56K |
| Common Stock Direct | 8/31/2026 | S · Sale | −10K | $70.24 | $702.40K | 14.6% | 68.56K | 58.55K |
| Total | +0.00 | -$469.80K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
23.26
Held after
0.00
Exercisable
—
8/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) Direct | Common Stock10K shares | 8/31/2026 | M · Option Exercise | −10K | 23.26 | — | 0.00 |